Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-30 Purchase | 2024-02-01 4:47 pm | ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 555,555 | $18 | $9,999,990 | 4,484,672 (Indirect) | View |
2023-06-13 Sale | 2023-06-15 7:25 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 1,198,128 | $188.88 | $226,306,339 | 142,888,241 (Indirect) | View |
2023-06-08 Sale | 2023-06-12 9:57 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 2,956,689 | $201.98 | $597,183,858 | 144,086,369 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-30 Conversion | 2024-02-01 4:47 pm | N/A N/A | ArriVent Biopharma Inc. | AVBP | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 63,691,020 | $0 | 4,484,672 (Indirect) | View |
2022-08-22 Other | 2022-08-24 4:15 pm | N/A N/A | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 7,800 | $0 | 147,050,858 (Indirect) | View |
Ownership | 2020-07-14 09:00 am | N/A N/A | BeiGene Ltd. | BGNE | HILLHOUSE CAPITAL ADVISORS LTD. HILLHOUSE CAPITAL MANAGEMENT LTD. 10% Owner | 0 | $0 | 147,035,258 (Indirect) | View |
Ownership | 2019-11-20 9:50 pm | N/A N/A | Cellular Biomedicine Group Inc. | CBMG | HILLHOUSE CAPITAL ADVISORS LTD. 10% Owner | 0 | $0 | 235,214 (Indirect) | View |